non-small cell lung cancerALK + lymphomaAmerican Italian Cancer Foundationpembrolizumab
… kinase (ALK)-driven malignancies, including ALK + lymphoma and non-small cell lung cancer (NSCLC); however, resistance and relapse remain major challenge…
1articles mentioning diseases
1disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: ALK + lymphoma ×
ALK + lymphoma
This disease is selected. Its supporting articles are shown below.